Hepatitis B vaccination coverage amongst healthcare workers in a tertiary academic hospital in Gauteng province, South Africa. 2022

Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
Department of Public Health Medicine, Faculty of Health Sciences, Sefako Makgatho Health Science University, Pretoria, South Africa.

Chronic infection with hepatitis B virus (HBV) is a major public health concern in South Africa. Hepatitis B virus is a highly infectious blood-borne virus causing liver disease. Healthcare workers (HCWs) are at high risk of occupational exposure. This study aimed to investigate HBV vaccination amongst HCWs at a tertiary academic hospital in Gauteng province, South Africa. Self-administered questionnaires were used to collect data from 500 consecutively sampled HCWs. Data were analysed using Stata version 12. A total of 460 HCWs participated in the study. Most were women (68.7%), < 40 years of age (66.9%) and worked for < 10 years (66.0%). Almost 50.0% were either doctors or medical students and 40.3% were nurses or student nurses. Most HCWs in the age group of < 30 years (79.4%) had received at least 1 dose of HB vaccine. Prevaccination immunity screening was conducted on 17.5% of the HCWs, and only 11.0% reported to be protected against HBV. About 49.0% of HCWs were fully vaccinated. Post-vaccination immunity testing was conducted on 15.1%, and 24.0% of HCWs paid for vaccinations. Nursing staff and those with > 10 years of work experience were 2.5 and 2.6 times more likely to be vaccinated, respectively. Cleaning staff were less likely to be vaccinated. Although not all HCWs were fully vaccinated, our study found a higher proportion of fully vaccinated HCWs than previously reported in Gauteng Province. It is recommended that HB vaccination be promoted and a local vaccination policy, aligned with the national policy, be developed and implemented for all HCWs at the tertiary academic hospital.

UI MeSH Term Description Entries

Related Publications

Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
June 2011, Vaccine,
Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
December 2018, BMC research notes,
Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
August 2021, Current opinion in immunology,
Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
December 2022, Vaccines,
Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
October 1998, Infection control and hospital epidemiology,
Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
June 2006, The Journal of hospital infection,
Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
September 2022, African health sciences,
Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
August 2013, Journal of infection and public health,
Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
August 2020, South African family practice : official journal of the South African Academy of Family Practice/Primary Care,
Lufuno L Razwiedani, and Ntlogeleng M Mogale, and Muthuhadini P B Mawela
June 2023, African journal of reproductive health,
Copied contents to your clipboard!